ReutersReuters

Revelation Biosciences Inc expected to post a loss of $4.45 a share - Earnings Preview

RefinitivMeno di 1 minuto di lettura
  • Revelation Biosciences Inc REVB is expected to show no change in quarterly revenue when it reports results on August 7 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Revelation Biosciences Inc is for a loss of $4.45 per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Revelation Biosciences Inc is $512.18, about 99.5% above its last closing price of $2.54

Accedi o crea un account gratuito per leggere queste notizie